AVITA Medical, Inc. (RCEL)

NCM – Real vaqt narxi. Valyuta: USD

7.89

-0.31 (-3.78%)

Bozor ochiq: Aug 12, 2026, 2:52 PM EDT

8.20

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:59 PM EDT

09.08.2026

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, President and Chief Executive Officer, and David O'Toole, Chief Financial Officer, on August 12, 2026, at 4:00 p.m.

07.08.2026

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

VALENCIA, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced it will be participating at the Canaccord Genuity 46th Annual Growth Conference in Boston, taking place August 11–13, 2026.

07.08.2026

Avita Medical Q2 Earnings Call Highlights

Avita Medical NASDAQ: RCEL reported second-quarter 2026 revenue of $21.7 million, up 18% from a year earlier and 13% sequentially, as growth in its RECELL wound-care product and newer portfolio offerings supported results.

07.08.2026

AVITA Medical, Inc. (RCEL) Q2 2026 Earnings Call Transcript

06.08.2026

AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

VALENCIA, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,” or the “Company”), today reported financial results for the second quarter ended June 30, 2026.

AVITA Medical, Inc. (RCEL)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

AVITA Medical, Inc. (RCEL)

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

Avita Medical Q2 Earnings Call Highlights

AVITA Medical, Inc. (RCEL) Q2 2026 Earnings Call Transcript

AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

Avita Medical Q2 Earnings Call Highlights

AVITA Medical, Inc. (RCEL) Q2 2026 Earnings Call Transcript

AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

Search stocks

AVITA Medical, Inc. (RCEL)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

AVITA Medical, Inc. (RCEL)

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

Avita Medical Q2 Earnings Call Highlights

AVITA Medical, Inc. (RCEL) Q2 2026 Earnings Call Transcript

AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

Avita Medical Q2 Earnings Call Highlights

AVITA Medical, Inc. (RCEL) Q2 2026 Earnings Call Transcript

AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven